Showing 1 - 6 results of 6 for search 'Frank M Speetjens', query time: 0.10s Refine Results
  1. 1
    Treatment results for patients with squamous-cell carcinoma of the anus, a single institution retrospective analysis

    Treatment results for patients with squamous-cell carcinoma of the anus, a single institution retrospective analysis by Karen J. Neelis, Django M. Kip, Frank M. Speetjens, Yvette M. van der Linden

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types

    Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types by Monique K. van der Kooij, Frank M. Speetjens, Sjoerd H. van der Burg, Ellen Kapiteijn

    Published 2019-06-01
    Get full text
    Article
  3. 3
    Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center

    Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center by Richard E. Evenhuis, Ibtissam Acem, Anja J. Rueten-Budde, Diederik S. A. Karis, Marta Fiocco, Desiree M. J. Dorleijn, Frank M. Speetjens, Jakob Anninga, Hans Gelderblom, Michiel A. J. van de Sande

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma

    Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma by Julius C. Heemelaar, Jeroen Janson, Jerry Braun, Frank M. Speetjens, Michiel A. J. van de Sande, Juan D. V. Hugo, Daniela Q. C. M. Barge-Schaapveld, Saskia L. M. A. Beeres, Laurens F. Tops, Hans Gelderblom, M. Louisa Antoni

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period

    Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period by Thaïs M. L. Tong, Esther Bastiaannet, Frank M. Speetjens, Christian U. Blank, Gregorius P. M. Luyten, Martine J. Jager, Marina Marinkovic, T. H. Khanh Vu, Coen R. N. Rasch, Carien L. Creutzberg, Jan-Willem M. Beenakker, Henk H. Hartgrink, Jacobus J. J. Bosch, Emine Kiliç, Nicole C. Naus, Serdar Yavuzyigitoglu, Caroline M. van Rij, Mark C. Burgmans, Ellen H. W. Kapiteijn

    Published 2023-11-01
    Get full text
    Article
  6. 6
    Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions

    Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16... by Hans Gelderblom, Sjoerd H van der Burg, Ferry Ossendorp, Peggy J de Vos van Steenwijk, Mariette I E van Poelgeest, Inge Roozen, Willem-Jan Krebber, Cornelis J M Melief, Frank M Speetjens, Marij J P Welters, Nikki M Loof, Sanne Boekestijn, Catharina A H Janssen, Marije Slingerland, Gijs G Zom, A Rob P M Valentijn, Nico J Meeuwenoord, Gijs A van der Marel, Dmitri V Filippov

    Published 2022-10-01
    Get full text
    Article

Search Tools: